Nxera Pharma UK Limited

Stephen Paul Watson

Miles Stuart Congreve

Giles Albert Brown

Julie Elaine Cansfield

Andrew David Cansfield

Francesca Deflorian

Nigel Alan Swain

Michael Alistair O'brien

Gregory R Ott

John Andrew Christopher

Sarah Joanne Bucknell

Andrea Bortolato

The disclosures herein relate to novel compounds of Formula (1); and salts thereof, wherein A, A, Q, X, R, Rand Rare defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with CGRP receptors.

CGRP antagonist compounds

The disclosures herein relate to novel compounds of Formula (1a): and salts thereof, wherein W, Z, L, Rand Rare defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with CGRP receptors.

Growing community of inventors

Cambridge, United Kingdom

Stephen Paul Watson